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ABSTRACT
Background: Smartphone technologies and mHealth applications (or apps) promise unprecedented 
scope for data collection, treatment intervention, and relapse prevention when used in the field of
substance abuse and addiction. This potential also raises new ethical challenges that researchers, 
clinicians, and software developers must address. Aims: This paper aims to identify ethical issues in 
the current uses of smartphones in addiction research and treatment. Methods: A search of three
databases (PubMed, Web of Science and PsycInfo) identified 33 studies involving smartphones or 
mHealth applications for use in the research and treatment of substance abuse and addiction. A 
content analysis was conducted to identify how smartphones are being used in these fields and to 
highlight the ethical issues raised by these studies. Results: Smartphones are being used to collect 
large amounts of sensitive information, including personal information, geo-location, physiological 
activity, self-reports of mood and cravings, and the consumption of illicit drugs, alcohol and nicotine. 
Given that detailed information is being collected about potentially illegal behaviour, we identified 
the following ethical considerations: protecting user privacy, maximising equity in access, ensuring 
informed consent, providing participants with adequate clinical resources, communicating clinically 
relevant results to individuals, and the urgent need to demonstrate evidence of safety and efficacy 
of the technologies. Conclusions: mHealth technology offers the possibility to collect large amounts 
of valuable personal information that may enhance research and treatment of substance abuse and 
addiction. To realise this potential researchers, clinicians and app-developers must address these
ethical concerns to maximise the benefits and minimise risks of harm to users.
Keywords: smartphones, mHealth, addiction, substance abuse, ethics, research, treatment.
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INTRODUCTION
Smartphones are a powerful and ubiquitous technology that combines mobile computing with 
telecommunication capabilities (Mosa, Yoo, & Sheets, 2012). In 2011, there were over 6 billion 
phone subscriptions reaching 87% of the world’s population (ITU, 2011). A recent survey found that 
43% of global respondents have a smartphone (Poushter, 2016). For countries such as Australia or 
the United States, this figure approaches three-quarters (Poushter, 2016). There is growing interest 
in the use of smartphones and other mobile technologies for conducting research on drug use and
addiction and intervening to reduce drug use and its harmful effects (Kuntsche & Labhart, 2014; 
Meurk, Hall, Carter, & Chenery, 2014). 
The ability of smartphones to run third party software applications (or apps) has generated interest 
in their use for research in substance abuse and addiction. Smartphones overcome many of the 
traditional limitations of addiction research that rely upon pen and paper surveys or diaries and 
retrospective recall. Although gathering retrospective self-report may be cost-efficient and 
convenient, it has been found to underestimate substance abuse (Kuntsche & Labhart, 2014). Self-
reported drug use can be under-reported if participants are unwilling to reveal the true amount 
consumed. It may also be subject to recall bias when users only remember some of their total drug 
consumption (Kuntsche & Labhart, 2014). Surveys of drug use generally underrepresent heavy 
substance abusers in the population (Kuntsche & Labhart, 2014). Less intrusive smartphone 
technologies can encourage a wider section of the population to participate in surveys. Less time is 
taken to fill out lengthy questionnaires and diaries, and prompts can be sent throughout the day to 
collect a greater range of data at more regular intervals (Kuntsche & Labhart, 2014).
Smartphones are also being looked at for use in healthcare settings to improve diagnosis and 
personalise treatment (Mosa et al., 2012). Smartphones may enable clinicians and other health care 
professionals to deliver clinically important information in a uniquely timely way. For example, data 
collected by a smartphone could trigger clinically relevant messages to the user prior to any drug use
(Luxton, McCann, Bush, Mishkind, & Reger, 2011). The use of smartphone technologies for this 
purpose has been termed mHealth (Tamony, Holt, & Barnard, 2015).
mHealth falls within the broader field of electronic research or e-research (Kypri & Lee, 2009; Miller
& Sønderlund, 2010). E-research is commonly used to study human participants from populations 
difficult to identify, recruit and retain in research and treatment. Advantages of mHealth and e-
research in non-therapeutic research (e.g. epidemiological, social and behavioural, humanities 
research) (Barratt, 2012; Meurk et al., 2014; Miller, Johnston, McElwee, & Noble, 2007; Shearer et 
al., 2007), include: increased participant comfort and perceived anonymity that encourages more 
honest disclosure; improved consent processes (Ford Ii et al., 2015; Monney, Penzenstadler, Dupraz, 
Etter, & Khazaal, 2015; R. Patel et al., 2015); reduced research costs; and fewer data errors (Miller et 
al., 2007; Monney et al., 2015). These approaches have also proven beneficial with human 
participants in therapeutic research domains (i.e. prevention, treatment and other interventions) 
include greater capacity to recruit participants for clinical studies, more efficient intervention 
delivery, improved monitoring of adherence to treatment protocols (Vahabzadeh, Lin, Mezghanni, 
Epstein, & Preston, 2009), and capacity to produce significant intervention effects (Amstadter, 
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Broman-Fulks, Zinzow, Ruggiero, & Cercone, 2009; Neil, Batterham, Christensen, Bennett, & Griffiths, 
2009).
For both research and treatment of addiction, smartphone monitoring of substance use or 
treatment is possible through passive data collection or via direct input from patients. Smartphone 
apps can prompt and record a patient’s self-reported drug consumption and cravings, commonly 
referred to as Ecological Momentary Assessment (EMA) (Serre, Fatseas, Swendsen, & Auriacombe, 
2015). Smartphone technologies may passively record patterns of movement within the 
environment, for example, via global positioning systems (GPS), wireless local area networks (or Wi-
Fi), Bluetooth, accelerometers, gyroscopes, pressure-sensors, proximity-sensing magnetometers, 
barometers, humidity sensors, temperature sensors, and ambient light sensors (Luxton et al., 2011).
Microphones and cameras are able to record images and sounds, including personal conversations, 
in the vicinity of the phone (Pei et al., 2013). From these data it is possible to deduce rich social 
information about an individual, including their identity, gender, age, marital status, social status, 
where they live, where their children go to school, health, sex life, religion, mood, and whether they 
visit a therapist, and if so how often, or how regularly they visit drinking or gambling establishments
(A. Carter, Liddle, Hall, & Chenery, 2015; Gasson, Warwick, Kosta, Royer, & Meints, 2011; King, 2011; 
Pei et al., 2013; Shilton, 2009).
Physiological information such as heart rate, blood pressure and substance concentration levels may 
be measured using additional sensors. Remote monitoring devices, for example, are being 
developed to continuously monitor physiological responses or precursors to cravings or relapse in 
persons being treated for addiction (Boyer, Smelson, Fletcher, Ziedonis, & Picard, 2010; Yu et al., 
2012). Smartphones can also be adapted to directly monitor physiological responses to drug 
consumption, such as sensor bands that are able to detect electro-dermal activity, body motion and 
skin temperature (Boyer et al., 2012). This information may be linked to other electronic databases, 
either commercially available or through agreement with other government agencies (e.g. personal 
medical records). Algorithms may then be developed to identify behavioural patterns indicative of
treatment progress, such as treatment response and triggers for cravings and behaviour that 
increases the risk of relapse (Ahsan et al., 2013). In order for the technology to provide effective
treatments, robust research will need to be conducted. Given the sensitive information being 
collected and intrusive nature of the equipment, a number of ethical issues arise.  
Ethical issues
mHealth raises novel ethical issues for research because it differs from traditional means of human 
participant recruitment, consent, data collection, and analysis (A. Carter et al., 2015). mHealth 
methods alter the nature, dynamics and potential consequences of research participation and are 
evolving rapidly. The potential negative consequences of participation in mHealth research are
particularly salient for those with stigmatised disorders or behaviour, such as those with a drug 
addiction or who use illicit drugs (Meurk et al., 2014).
There are also concerns surrounding the clinical applications of mHealth technology for addiction or 
substance abuse treatment. Confidentiality and informed consent procedures may need to be 
revised to consider storage locations and security. Given the wide market available and possibility 
for corporate interest, evidence of safe and effective treatments may need to be highlighted prior to 
distribution among potentially vulnerable users.  The speed of growth of the smartphone app 
Page 5 of 26
Ac
ce
pte
d M
an
us
cri
pt
5
market appears to have outpaced the medical fraternity’s ability to address these ethical challenges 
(Boyce, 2012). 
The pace of development is “forcing researchers and research regulators to rethink and re-evaluate 
such fundamental research ethics issues as privacy, informed consent, ownership, recruitment, 
public versus private space, research and scientific integrity itself” (Buchanan & Hvizdak, 2009, p. 37).
The World Health Organization has recognised the need for greater consideration of the ethical use 
of electronic or mobile research and health. Unfortunately, progress in developing ethical guidance 
has been slow. A recent NHMRC Australian Health Ethics Committee (AHEC) consultation paper on 
ethical issues in alcohol and drug research acknowledged: “The National Statement was published 
before the ethical issues raised by these developments became apparent so it currently provides no 
specific guidance for Internet-based or other forms of online research” (NHMRC, 2011, p. 27). This is 
particularly the case for mobile technologies. Although recent guidelines have been outlined on the 
use of digital data in research (Clark et al., 2015), ethical guidelines are still required to clarify best 
practice in the use of mHealth technology (A. Carter et al., 2015).
It is important that ethical regulation of the research and clinical use of smartphones keeps pace
with the rapid developments in these technologies. Traditional ways of ensuring the confidentiality 
and privacy of research data collected on drug use and behaviour are not sufficient to deal with the 
sophisticated array of personal data that are collected via smartphone technologies. Research teams 
and clinicians must understand these ethical implications if they are to maximise the promise of this 
technology and minimise any unintended harms. These ethical concerns depend on how the 
technology is being used, and the sorts of safeguards that are put in place. The use of appropriate 
technical safeguards during the development of apps can mitigate many of these concerns (e.g. by 
the use of secure in-boxes, maximising user control over data recorded, transmission of data using 
secure methods, and providing access to devices for those that do not have them) (A. Carter et al., 
2015). The current lack of ethical guidelines in this area can “result in researchers acting with less 
consideration, and even behaving unethically towards their study subjects” (Bober, 2004, p. 308).
In order to better understand the ethical issues raised by the use of smartphones in addiction 
research and treatment, this paper aims to review the ways in which smartphone technologies are 
currently being employed in the field. From this ethical review, we will conclude with a set of 
recommendations for the development and use of mHealth apps for researchers and clinicians in the
field of substance abuse and addiction.
METHODS
A search of three electronic databases (PubMed, PsycInfo and Web of Science) was performed by HC
using the following terms: (“substance use” OR “substance abuse” OR “drug dependence” OR 
addict* OR alcohol* OR smok* OR tobacco OR cannabis OR marijuana OR heroin OR cocaine OR 
opioid OR opiate) AND (mHealth OR smartphone OR iPhone OR “mobile phone app”) NOT 
(“smartphone addiction”).Eighty-four articles were downloaded to an Endnote database for further 
analysis of eligibility. Titles and abstracts of the articles were examined to identify studies fulfilling 
the following criteria: 1) involving mHealth apps or smartphones (defined as mobile phones with on 
board sensors, internet capability and the ability to run third party apps); 2) for use in the research 
or treatment of substance abuse or addiction. Articles not fulfilling these criteria were excluded (n = 
22). Full-text analysis excluded a further 30 publications because they either did not fulfil the 
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inclusion criteria, provided only a case report or general review of the topic or re-published data 
(Epstein et al., 2009; McTavish, Chih, Shah, & Gustafson, 2012). Article reference lists were screened 
identifying one additional study (Yu et al., 2012). The final analysis comprised of 33 unique papers 
describing 35 mHealth/mobile phone applications (see Figure 1).
[Figure 1 Trial Flow Diagram.]
Data Analysis
The data was transcribed into the Statistical Package for Social Sciences (SPSS) Version 23.0 software 
to be analysed quantitatively and also tabulated in Microsoft Word for qualitative analysis. Of the 33
studies included in this analysis, 10 used smartphone technology to collect research data from 
participants (Research apps, see Table S1) and 23 focused on the treatment or management of 
addiction and substance abuse (Clinical apps, see Table S2). A content analysis identified the
following relevant themes: substance investigated, study aims and design, information recorded as 
part of the study, how information was stored and transferred from the smartphone, and the ethical 
considerations highlighted in the study. We then examined the ethical concerns raised by these 
themes and assessed the measures suggested in the literature to mitigate these concerns. We then 
conducted an ethical analysis employing a pluralistic principlist approach (Beauchamp & Childress, 
2009) to identify additional ethical concerns that warrant further consideration by researchers, 
clinicians, and app developers.
RESULTS
Substance Investigated
Approximately half of the apps focused on tobacco abuse and one-third involved alcohol use (see 
Table 1); two examined heroin addiction, and one cocaine abuse. Three studies examined addiction 
in general, either covering a range of substances or not specifying the substance of addiction.
[Table 1 Substance of focus.]
Study Design and Aim
The majority (37.1%) of studies analysed were randomised controlled trials (RCT) of clinical 
smartphone apps. Approximately one-third (31.4%) were observational studies of intervention
effects on participants’ behaviour; seven of these were cohort studies and four were case-control 
studies. One-quarter of the applications reviewed were feasibility studies. Two papers were reviews 
of commercially available applications.
Five distinct aims of the apps were identified (see Table 2). Over half aimed to induce or support 
behaviour change, such as smoking cessation, or reduced alcohol consumption. Other applications 
aimed at: preventing the user from relapsing to drug use; assisting the user to monitor their
consumption; and encouraging medication adherence in the treatment of alcohol abuse.
More than half of the 10 research applications used text messaging and EMA protocols to assess 
relationships between cravings, substance use, mood or proximity to retail outlets for alcohol or 
tobacco. One study tested the reliability and validity of a mobile phone based breath carbon-
monoxide meter, while another aimed to investigate the prevalence of smoking in vehicles. Two 
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studies used smartphone apps to study the effects of alcohol on cognition: one used games to 
measure alcohol intoxication and compared this with blood alcohol concentration; the other
examined the effectiveness of a program to increase executive functioning of alcohol abusers. 
[Table 2 Purpose of application.]
Personal Information Recorded
The apps collected a range of demographic and personal information (see Table 3). A majority 
required users to record their regular consumption habits, daily drug use, cravings, or triggers of 
cravings. Over half of the apps obtained personal demographic information that included age, 
gender, ethnicity, education level and employment. Users’ locations were tracked using GPS or other 
geo-locating sensors by more than one-fifth of the applications and three included devices that 
measured physiological data. Three obtained this information via user self-report. Six apps collected 
information on participants’ medical history or their use of prescribed medications. More than one-
third of apps collected information on users’ goals for recovery, such as personal motivations or 
reasons for abstinence. 
[Table 3 Type of information collected.]
Data Storage and Transfer
One-quarter of the studies did not address storage security or methods of transferring the 
information from the device. Almost half (48.6%) utilised ‘secure’ online storage banks, such as ‘the 
cloud’, and wireless or 3G servers to transfer this information (Ahsan et al., 2013; BinDhim, 
McGeechan, & Trevena, 2014; Hertzberg et al., 2013; Reitzel et al., 2014; Renner, 2012; Struik & 
Baskerville, 2014). The remainder either stored information on local devices (25.7%). In terms of 
transfer of information, over half of the studies transferred data using online pathways and 
approximately one-fifth (22.9%) transferred information using localised, offline devices. 
Ethical Considerations
After reviewing the literature, we identified the following ethical issues as emerging themes:
protecting the privacy of the information collected (assessed by attempts to ensure user anonymity, 
encryption of data, consideration of storage and transfer security, password protection, private 
inboxes, and user control); ensuring equal access to the technology for all individuals; and providing 
appropriate clinical information to the individual (including recommendations for supportive 
resources for substance abuse treatment) (see Table 4).
Privacy
Over one third of the applications reported implementing processes that aimed to preserve user 
anonymity (e.g. unidentified usernames, de-identification of the data). Eleven apps used data
encryption methods, where data is scrambled to make it indecipherable by third parties and one-
fifth used password-protection. Twenty apps provided users with an element of control over the 
utility of the app. For example, a number of apps sought to maintain user privacy by providing the 
participant with the ability to turn off alerts at certain times (Keoleian, Stalcup, Polcin, Brown, & 
Galloway, 2013; Kirchner et al., 2013; McTavish et al., 2012; van Mierlo et al., 2014). One application 
allowed the user to switch off location services when desired (McTavish et al., 2012), potentially 
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reducing the amount of unnecessary data collected and the possibility of a third-party identifying the 
user through data profiling (Gasson et al., 2011).
Of the 18 applications that used text messaging, only three incorporated a separate or private inbox 
for the user (e.g. (Hasin, Aharonovich, & Greenstein, 2014; Haug, Kowatsch, Castro, Filler, & Schaub, 
2014)). To ensure privacy from third party access, if the device is lost or stolen, a small number of 
apps used password protection (e.g. (Hertzberg et al., 2013; Renner, 2012; van Mierlo et al., 2014)). 
Equal access to the technology
Fourteen of the studies reviewed took steps to ensure that individuals in the lower socioeconomic 
population had access to mHealth technology. A range of methods were observed, such as providing 
the participant with a smartphone device (Dulin, Gonzalez, & Campbell, 2014; Ingersoll et al., 2014; 
Johnson, Barrault, Nadeau, & Swendsen, 2009), recruiting participants from treatment centres 
(Epstein et al., 2009; Johnson et al., 2009; Watkins et al., 2014) or focusing primarily on individuals of 
lower income (Reitzel et al., 2014; Wen et al., 2014). Yet more than half of the studies required
participants to own a smartphone device or have access to the Internet (Keoleian et al., 2013; 
Whittaker, 2011) in order to be eligible to participate.
Communication of clinical information
Over half of the studies provided external support resources for participants, through either clinical 
treatment as part of the study (Boyer et al., 2012; Epstein et al., 2009; Ingersoll et al., 2014; 
McTavish et al., 2012), personal care or online interactive resources (Dulin et al., 2014; McTavish et 
al., 2012). However, almost half of the studies did not provide any resources or clinically relevant 
information for users. Finally, six apps were developed alongside not-for-profit, independent 
organisations, such as Quit Victoria (Ploderer, Smith, Pearce, & Borland, 2014) or the Cancer Council 
(Borland, Balmford, & Benda, 2013; Buller, Borland, Bettinghaus, Shane, & Zimmerman, 2014).
[Table 4 Ethical issues considered.]
DISCUSSION
A range of research methods were observed in the 33 unique studies of smartphone technologies in 
addiction research and treatment and it was encouraging to find the most common being 
randomised controlled trials, the ‘gold standard’ research method. Yet, despite some in-depth, 
potentially identifiable information being collected about the user, many studies may have 
overlooked the reliability of their security measures. Such oversight has implications on the 
participant’s privacy and informed consent. Given the potential vulnerability of the population in 
question, ethical issues may arise when using mHealth technology for treating substance abuse
related to the equal availability of smartphone technology for all, communication of clinically 
relevant information, evidence of safety and effectiveness of the app as well as the process of app 
design. 
Privacy
The most prominent ethical concern with mHealth technology is protecting the privacy of users’ 
personal information. The mHealth apps we reviewed collected a range of sensitive information, 
such as users’ demographic characteristics, drug use, mood or cravings. From such data, it may be 
possible for a third party to identify persons engaging in criminal behaviours (e.g. consumption or 
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purchase of illicit drugs), the locations at which they did so, and the details of others who may also 
be involved. Given the sensitivity of the information collected, researchers, clinicians and app 
developers have an ethical obligation to take steps to ensure that third parties cannot access such 
information and to be aware of the limitations of their promises to protect users’ privacy. We are 
unable to discern from this study whether the informed consent process met these 
recommendations. The inability to ensure anonymity and guarantee privacy is seldom acknowledged 
in the mHealth literature. Although a breach of a user’s privacy may be viewed as unlikely, this is an 
area that requires greater attention.
Data storage and transfer
Despite collecting information about potentially illegal behaviours, many studies either did not 
address storage security, or utilised online storage banks where the level of security is unknown. The 
risks of such storage locations need to be addressed. Researchers and clinicians cannot guarantee 
that information stored online will not be accessed by third parties, despite password protection, as 
recent high profile breaches of cloud storage illustrate (Chu et al., 2013; "Cloud hack on celebrities," 
2014; Timberg, 2014). Furthermore, entrusting data with third-party networks, via transmission or 
storage, can increase the possibility of hacking. There is also a question about data ownership by
telecommunication companies and cloud storage providers through which the data is transmitted or 
stored (e.g. Internet service providers (ISP), Google, Amazon) (He, Naveed, Gunter, & Nahrstedt, 
2014).
Third-party access
There are limits to the extent to which researchers, clinicians and app-developers can guarantee the 
privacy of participant information, despite using off-line, secure storage. Drug use is often illicit and 
may be of interest to both criminal and civil courts (e.g. Family Courts in custody disputes). If 
presented with a subpoena, researchers and clinicians are legally required to hand over participant 
information that is recorded on drug-related apps. Furthermore, many drug users are engaged in 
illegal behaviour (by definition in using an illegal drug), and frequently come under the surveillance 
of the authorities. If there is suspicion that they have engaged in illegal activities, law enforcement 
officials have the authority to demand access to smartphone data, which may record proof of illegal 
activity of study participants (e.g. their illicit drug use or property crimes) or others (e.g. the location 
of their drug dealers). 
In addition to carrying larger volumes of personal data, mobile phones are often permanent 
accompaniments that are easily visible and accessible by third parties. Despite efforts to reduce the 
risk of third parties accessing the app or user information, the simple presence of an app on a phone 
may be enough to disclose that the person has an addiction. These are salient issues where users 
may be subject to significant stigmatisation and social discrimination (e.g. by employers, educators, 
insurers). Steps should be taken to mitigate unintended discovery of the app or the data recorded. 
These limitations should also be acknowledged through transparent and robust informed consent 
procedures (see below).
User anonymity
A number of app designers have taken steps to ensure that the data they collect does not identify 
the user. For example, anonymous usernames were employed and specific details were removed 
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from the data that could uniquely identify a person (e.g. personal address) (Ploderer et al., 2014; 
Stoner & Hendershot, 2012; van Mierlo et al., 2014). Although these attempts may increase user 
anonymity, they can be ineffective if the app passively collects geo-location data, as was found for 
two apps (BinDhim et al., 2014; Boyer et al., 2012).
Data encryption methods were utilised by some apps, where data is scrambled so that it is 
indecipherable by third parties. Yet the security of this procedure is uncertain as it is possible for 
codes to be broken or cracked with modern computing methods (Wei, Murugesan, Kuo, Naik, & 
Krizanc, 2013). Although most of the apps that used encryption methods also de-identified the data 
collected (Ahsan et al., 2013; BinDhim et al., 2014; Boyer et al., 2012; Gajecki, Berman, Sinadinovic, 
Rosendahl, & Andersson, 2014; Gamito et al., 2014; Renner, 2012; Stoner & Hendershot, 2012; van 
Mierlo et al., 2014), collecting a wide range of data, including geo-location, renders it possible to 
construct a data profile that may identify the user (Gasson et al., 2011).
Some features included in a number of apps may threaten users’ privacy. For example, alerts
employed by smartphones to collect research data may attract the attention of third parties (B. L. 
Carter et al., 2008; Dulin et al., 2014; Johnson et al., 2009). Such approaches may increase the 
privacy and control a participant has over their data and the intrusiveness of the app, but at the cost 
of reducing its research value if data are missed. This trade off must be carefully balanced during 
research design and ethical review.
Informed Consent
It is imperative that participants in smartphone research or users of mHealth apps for treatment of 
addiction are fully informed of the potential risks to their privacy and the limitations on researchers 
and clinicians’ ability to protect this privacy. Presently, the technological and legal implications of 
these devices may be difficult for both participants and researchers to comprehend. For example, 
researchers who used an mHealth app for individuals recovering from alcohol dependence
conducted focus groups to examine users’ perceptions of GPS tracking (D. Gustafson et al., 2011). 
Most users were quite open to location tracking, provided the data were only shared with their 
permission. Despite the limited ability to protect privacy of information on illicit substance use, the 
researchers did not clarify the limits to privacy or describe the amount of information that may be 
gleaned from the devices. 
Some long-term dependent drug users may have cognitive or learning impairments that interfere 
with their ability to understand the ethical implications raised by the technologically sophisticated 
use of smartphone apps. Researchers and clinicians must take this into consideration by designing
informed consent procedures that explain this technologically complex information in ways that 
facilitate comprehension (e.g. by using visual aids and testing comprehension). Furthermore, as the 
legal situation is different in different countries, researchers and clinicians should be aware of the 
laws affecting their area.
Equal Access to mHealth Technology
The expense of buying smartphones and telephone plans may prevent vulnerable populations from 
accessing mHealth services or participating in research. This can amplify inequities in access to 
healthcare. While there has been a rapid growth in mobile phone coverage in recent years, some 
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segments of the population still lack access (Labrique, Kirk, Westergaard, & Merritt, 2013). A recent 
study on mobile phone use in substance abuse patients found that although the majority owned a 
mobile phone, only half had smartphone capabilities and three-quarters were on pay-as-you-go 
contracts (Milward, Day, Wadsworth, Strang, & Lynskey, 2015). mHealth applications that require 
internet access and costly data transmission may be unaffordable and thus inaccessible for 
significant portions of the drug dependent population. 
More than half of the studies reviewed required participants to own a smartphone device or have 
access to the Internet in order to be eligible to participate. These requirements exclude individuals 
who may not have access to smartphone technology. Given that drug users tend to be over-
represented in lower socioeconomic populations, there is an ethical imperative to ensure that these 
patients are not prevented from benefitting from mHealth monitoring (Labrique et al., 2013). 
Furthermore, study results will be skewed if such a population is ignored and as a result those in 
most need of rehabilitation or support are excluded from participating in important research or from 
receiving treatment benefits.
Communication of Clinical Information to Participants
A critical decision in using smartphones for clinical purposes is how to communicate results to users.
The provision of immediate and ubiquitous feedback of information has the potential to empower 
and assist patients to better manage their health and to improve clinician/patient relationships
(Boyce, 2012). This issue was only considered by a small number of studies. One, for example, 
provided detailed personalised feedback in the form of graphs and summaries and, after 30 days, 
patients met with counsellors to ensure that they understood the feedback (Hasin et al., 2014). 
Other apps fulfilled this ethical requirement by providing users with features mapping their self-
reported progress in the form of monetary or health benefits trackers (BinDhim et al., 2014; Bricker 
et al., 2014; Struik & Baskerville, 2014). To be clinically meaningful, however, the findings must be 
scientifically robust and presented in a way that the patient understands. 
At a minimum, apps must provide information on clinical services and resources available to the 
person both via and external to the app. It is not only important that app developers and researchers 
facilitate access to clinical information and services, but also that they are factual and maximise 
benefits to the user.
Evidence of Safety and Effectiveness
In order to minimise any risk of harms to the users, app-developers should provide evidence of the 
safety and effectiveness of the apps before making them available to the public. This urgent need 
was recognized by the World Health Organization and other leading health agencies in the Bellagio 
call to action on global eHealth evaluation that called for rigorous evaluation “to generate evidence 
and promote the appropriate integration and use of technologies...to improve health and reduce 
health inequalities” (The Bellagio eHealth Evaluation Group, 2011, p. 1). One app, for example,
included alerts to warn users when they were entering a location where they may be at risk of a 
relapse to drinking (Dulin et al., 2014). Without evidence of safety and effectiveness, alerts such as 
this may unintentionally remind the user of an opportunity to use their drug and induce craving. 
Page 12 of 26
Ac
ce
pte
d M
an
us
cri
pt
12
Although some apps were developed alongside independent organisations, many that are publicly 
available are created by commercial developers who are not subject to the same ethical guidelines 
as university or hospital-based researchers (Abroms, Westmaas, Bontemps-Jones, Ramani, & 
Mellerson, 2013). Given the simplicity and cost-effectiveness of mHealth solutions, decision-makers 
may overlook the lack of robust empirical evidence in deciding whether to use them (Boyce, 2012). 
The implementation of untested mHealth interventions may result in failed projects, wasted 
resources, and poorer health outcomes for those using these services. In order to benefit the user, it 
is imperative that the mHealth apps used by researchers, clinicians, universities and hospitals are
supported by rigorous evidence of safety and efficacy (Boyce, 2012).
App Design and Development
The development and investigation of these apps requires engagement with users and other 
stakeholders to identify their concerns and develop processes that protect the participant and 
maximise the utility and effectiveness of the intervention. Focus groups were employed throughout 
the development process for a number of papers developing apps for smoking cessation (Giroux, 
Bacon, King, Dulin, & Gonzalez, 2014; Ybarra, Holtrop, Prescott, & Strong, 2014). Although important 
for enhancing user access and utility, issues related to participant privacy were not addressed. 
Researchers and app developers need to consider ethical issues when designing mHealth technology 
for addiction research and treatment purposes. A consideration of these issues should not be left 
until after an app has been designed. This will not optimally meet the ethical challenges, mitigate 
any risk of harm for users, or maximise participant autonomy. We propose a number of 
recommendations for the development and use of such technology for substance abuse and 
addiction (see Box. 1).
Limitations and Future Directions
The present paper has reviewed the literature on the use of mHealth technology for research and 
treatment of substance abuse or addiction. We have identified a number of ethical concerns and 
have provided recommendations for researchers, clinicians and app developers that would 
contribute to ensuring user privacy is maintained and standard ethical principles are not violated 
with the fast-developing technology. Due to the nature of the research, however, some limitations 
are acknowledged. The present review was limited to the use of smartphones published in academic 
journals only. This may have excluded  commercially available apps that were not being tested by 
researchers. A review of apps available on commercial platforms is recommended for future 
research. The use of smartphones in addiction research and treatment involves complex, technically 
specific research and knowledge. We believe that multidisciplinary working groups are needed to 
examine the complex technical issues involved in ensuring the ethical use of smartphone apps in 
research and treatment, and to develop a set of easily understood guidelines for both researchers 
and clinicians about the minimum standard ethical requirements for the design and use of this 
promising technology.
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Ethical Consideration Recommendations
Data storage and 
transfer
Serious consideration should be given to where the data is stored and how it is 
transmitted from the device. Online transmission and storage should be 
avoided in favour of localised storage units that can only be accessed by 
authorised personnel. Only data relevant to the aims of the study or purpose 
of the application should be collected. 
Data ownership If data is to be stored on third party networks, clear guidelines should be 
provided prior to data collection that outlines to all parties who has rights to 
access the data and which parties own the data.
Third-party access Password protection or private inbox features should be utilised to prevent 
accidental third party access to the app/device. Individuals should be informed 
of the potential for third parties to access their data, through legal means, or 
hacking. 
User anonymity Data encryption methods can reduce likelihood of third-party access to 
information but their limitations must be relayed to the user. Users need to be 
made aware if de-identification processes are not possible. Where possible, 
users should be given power to control how much information is collected and 
when.
Informed consent mHealth users need to be informed of the risks and benefits of the technology 
in a way that is clear and understandable. This includes limits to confidentiality 
and privacy, for example, court orders or subpoena.
Access to mHealth 
technologies 
Strategies need to be used to ensure that individuals from minority groups, 
such as lower socioeconomic populations or those with a disability, have equal 
access to the benefits of mHealth technology. Provision of devices to research 
participants will include those most in need and ensure a more representative 
sample.  
Communication of 
clinically relevant 
results
Feedback of clinically relevant information should be relayed to the user in a 
manner that they understand but only when there is strong empirical evidence 
to support the findings. Users should also be provided with access to external 
resources for evidence-based, clinical support for their addiction.
Evidence of safety and 
effectiveness
Interventions encompassed in mHealth technology should only be utilised if
prospectively shown to be safe, effective and of benefit to the consumer.
Regulation of mHealth 
products
A regulatory process is needed to carefully evaluate mHealth apps and require 
evidence of safety, effectiveness, and ethical conduct before routine public 
distribution and clinical use.
Box 1 Recommendations for researchers, clinicians, and app developers when using and designing
mHealth technology for therapeutic and non-therapeutic addiction research.
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CONCLUSIONS
Smartphone and mHealth technology provide unique possibilities for collecting valuable information 
about research and for the treatment of substance abuse and addiction. Given the wide scope of 
personal information that can be collected, the promise of these technologies also raise a number of 
ethical issues. Our analysis suggests that there is a lack of awareness of the ethical issues raised by 
their use, the implications for how the apps are developed, and how both research and clinical 
treatments are conducted. Given the sensitivity of information being collected (e.g. illegal 
behaviours), it is an ethical imperative for researchers, app-developers and clinicians to protect the 
rights and privacy of the users. There is currently a lack of attention to where information is being 
stored, the level of security involved, and how it is being transferred (He et al., 2014; Su, 2014). App-
developers and researchers need to ensure that apps are designed in a way that reduce the risk of 
personal information being accessed by third parties and maximises user anonymity. There is great
potential of mHealth technology, yet it is imperative that we first address these ethical 
considerations to ensure that we capitalise on the possible benefits of these technologies while 
minimising the potential risks to the users.
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Tables and Figures
Figure 1 Flow diagram for literature search and study inclusion.
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Table 1 Substance focus.
Substance N (%) References
Tobacco 17 (48.6%) (Ahsan et al., 2013; BinDhim et al., 2014; Borland 
et al., 2013; Bricker et al., 2014; Buller et al., 2014; 
B. L. Carter et al., 2008; Haug et al., 2014; 
Hertzberg et al., 2013; Kirchner et al., 2013; 
Meredith et al., 2014; V. Patel, Nowostawski, 
Thomson, Wilson, & Medlin, 2013; Ploderer et al., 
2014; Reitzel et al., 2014; Struik & Baskerville, 
2014; van Mierlo et al., 2014; Watkins et al., 2014; 
Whittaker, 2011)
Alcohol 12 (34.3%) (Bendtsen & Bendtsen, 2014; Dulin et al., 2014; 
Gajecki et al., 2014; Gamito et al., 2014; Hasin et 
al., 2014; Haug et al., 2014; Kauer, Reid, Sanci, & 
Patton, 2009; Matsumura, Yamakoshi, & Ida, 
2009; McTavish et al., 2012; Renner, 2012; Stoner 
& Hendershot, 2012; Yu et al., 2012)
Heroin 2 (5.7%) (Boyer et al., 2012; Epstein et al., 2009)
Cocaine 1 (2.9%) (Freedman, Lester, McNamara, Milby, & 
Schumacher, 2006)
General 3 (8.6%) (Campling, 2011; Ingersoll et al., 2014; Johnson et 
al., 2009)
Table 2 Purpose of mHealth applications.
Purpose N (%) References
Behaviour change 18 (51.4%) (Ahsan et al., 2013; Bendtsen & Bendtsen, 2014; 
BinDhim et al., 2014; Borland et al., 2013; Bricker 
et al., 2014; Buller et al., 2014; Dulin et al., 2014; 
Hasin et al., 2014; Haug et al., 2014; Hertzberg et 
al., 2013; Ingersoll et al., 2014; Ploderer et al., 
2014; Renner, 2012; Struik & Baskerville, 2014; 
van Mierlo et al., 2014; Whittaker, 2011; Yu et al., 
2012)
Relapse prevention 3 (8.6%) (Boyer et al., 2012; Campling, 2011; McTavish et 
al., 2012)
Medication adherence 1 (2.9%) (Stoner & Hendershot, 2012)
Monitor consumption 5 (14.3%) (Gajecki et al., 2014; Gamito et al., 2014; Kauer et 
al., 2009; Matsumura et al., 2009; V. Patel et al., 
2013)
Research only 8 (22.9%) (B. L. Carter et al., 2008; Epstein et al., 2009; 
Freedman et al., 2006; Johnson et al., 2009; 
Kirchner et al., 2013; Meredith et al., 2014; 
Reitzel et al., 2014; Watkins et al., 2014)
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Table 3 Type of information collected.
Type of Information 
Collected
N (%) References
Demographics 20 (57.1%) (Ahsan et al., 2013; BinDhim et al., 2014; Borland et al., 2013; 
Bricker et al., 2014; Buller et al., 2014; B. L. Carter et al., 2008; 
Epstein et al., 2009; Gajecki et al., 2014; Gamito et al., 2014; 
Haug et al., 2014; Hertzberg et al., 2013; Johnson et al., 2009; 
Kauer et al., 2009; Kirchner et al., 2013; Matsumura et al., 2009; 
McTavish et al., 2012; Reitzel et al., 2014; Struik & Baskerville, 
2014; van Mierlo et al., 2014; Watkins et al., 2014)
Location
Self-Reported 3 (8.6%) (Epstein et al., 2009; Freedman et al., 2006; V. Patel et al., 2013)
GPS tracking 8 (22.9%) (BinDhim et al., 2014; Boyer et al., 2012; Dulin, Gonzalez, King, 
Giroux, & Bacon, 2013; Kirchner et al., 2013; McTavish et al., 
2012; Reitzel et al., 2014; Struik & Baskerville, 2014; Watkins et 
al., 2014)
Consumption habits 26 (74.3%) (Ahsan et al., 2013; Bendtsen & Bendtsen, 2014; BinDhim et al., 
2014; Borland et al., 2013; Bricker et al., 2014; Buller et al., 2014; 
Campling, 2011; B. L. Carter et al., 2008; Dulin et al., 2014; 
Epstein et al., 2009; Freedman et al., 2006; Gajecki et al., 2014; 
Haug et al., 2014; Hertzberg et al., 2013; Johnson et al., 2009; 
Kauer et al., 2009; McTavish et al., 2012; Reitzel et al., 2014; 
Renner, 2012; Struik & Baskerville, 2014; van Mierlo et al., 2014; 
Watkins et al., 2014; Whittaker, 2011; Yu et al., 2012)
Cravings/Triggers 24 (68.6%) (Ahsan et al., 2013; BinDhim et al., 2014; Borland et al., 2013; 
Boyer et al., 2012; Bricker et al., 2014; Buller et al., 2014; B. L. 
Carter et al., 2008; Dulin et al., 2014; Epstein et al., 2009; 
Freedman et al., 2006; Hasin et al., 2014; Haug et al., 2014; 
Ingersoll et al., 2014; Johnson et al., 2009; McTavish et al., 
2012; Reitzel et al., 2014; Renner, 2012; Stoner & Hendershot, 
2012; Struik & Baskerville, 2014; van Mierlo et al., 2014; 
Watkins et al., 2014; Whittaker, 2011; Yu et al., 2012)
Physiological response 3 (8.6%) (Boyer et al., 2012; Meredith et al., 2014; Yu et al., 2012)
Medical history 6 (17.1%) (Borland et al., 2013; Bricker et al., 2014; Buller et al., 2014; 
Gamito et al., 2014; Johnson et al., 2009; van Mierlo et al., 
2014)
Daily drug use 30 (85.7%) (Ahsan et al., 2013; Bendtsen & Bendtsen, 2014; BinDhim et al., 
2014; Borland et al., 2013; Bricker et al., 2014; Buller et al., 
2014; Campling, 2011; A. Carter, Liddle, J., Hall, W., Chenery, H., 
2015; Dulin et al., 2014; Epstein et al., 2009; Freedman et al., 
2006; Gajecki et al., 2014; Hasin et al., 2014; Haug et al., 2014; 
Hertzberg et al., 2013; Ingersoll et al., 2014; Johnson et al., 
2009; Kauer et al., 2009; Matsumura et al., 2009; McTavish et 
al., 2012; Meredith et al., 2014; Ploderer et al., 2014; Reitzel et 
al., 2014; Renner, 2012; Stoner & Hendershot, 2012; Struik & 
Baskerville, 2014; van Mierlo et al., 2014; Watkins et al., 2014; 
Whittaker, 2011)
Goals for recovery 13 (37.1%) (Ahsan et al., 2013; BinDhim et al., 2014; Borland et al., 2013; 
Bricker et al., 2014; Buller et al., 2014; Campling, 2011; Hasin et 
al., 2014; Haug et al., 2014; McTavish et al., 2012; Stoner & 
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al., 2014; Haug et al., 2014; McTavish et al., 2012; Stoner & 
Hendershot, 2012; Struik & Baskerville, 2014; van Mierlo et al., 
2014)
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Table 4 Ethical issues considered.
Ethical consideration N (%) References
Privacy
User anonymity 13 (38.2%a) (Ahsan et al., 2013; BinDhim et al., 2014; Borland et al., 
2013; Freedman et al., 2006; Gajecki et al., 2014; Gamito et 
al., 2014; Haug et al., 2014; Matsumura et al., 2009; V. 
Patel et al., 2013; Renner, 2012; Stoner & Hendershot, 
2012; van Mierlo et al., 2014)
Data encryption 11 (32.3%b) (Ahsan et al., 2013; BinDhim et al., 2014; Boyer et al., 2012; 
Gajecki et al., 2014; Gamito et al., 2014; Haug et al., 2014; 
Meredith et al., 2014; Renner, 2012; Stoner & Hendershot, 
2012; Struik & Baskerville, 2014; van Mierlo et al., 2014)
Password protection 7 (24.1%c) (Boyer et al., 2012; Hasin et al., 2014; Haug et al., 2014; 
Hertzberg et al., 2013; V. Patel et al., 2013; Renner, 2012; 
van Mierlo et al., 2014)
User control 20 (69.0%d) (Bendtsen & Bendtsen, 2014; BinDhim et al., 2014; Bricker 
et al., 2014; Campling, 2011; B. L. Carter et al., 2008; 
Gajecki et al., 2014; Haug et al., 2014; Hertzberg et al., 
2013; Ingersoll et al., 2014; Kauer et al., 2009; McTavish et 
al., 2012; Ploderer et al., 2014; Reitzel et al., 2014; Renner, 
2012; Struik & Baskerville, 2014; van Mierlo et al., 2014; 
Watkins et al., 2014; Whittaker, 2011; Yu et al., 2012)
Private inbox 3 (16.7%e) (Buller et al., 2014; Hasin et al., 2014; Haug et al., 2014)
Equity in access 14 (46.7%f) (Boyer et al., 2012; A. Carter, Liddle, J., Hall, W., Chenery, 
H., 2015; Dulin et al., 2014; Epstein et al., 2009; Freedman 
et al., 2006; Gamito et al., 2014; Hasin et al., 2014; 
Ingersoll et al., 2014; Johnson et al., 2009; Kauer et al., 
2009; McTavish et al., 2012; Reitzel et al., 2014; Watkins et 
al., 2014; Yu et al., 2012)
Support resources 19 (55.9%g) (Bendtsen & Bendtsen, 2014; Bricker et al., 2014; Buller et 
al., 2014; Dulin et al., 2014; Epstein et al., 2009; Freedman 
et al., 2006; Gajecki et al., 2014; Hasin et al., 2014; Haug et 
al., 2014; Hertzberg et al., 2013; McTavish et al., 2012; 
Ploderer et al., 2014; Reitzel et al., 2014; Struik & 
Baskerville, 2014; van Mierlo et al., 2014; Watkins et al., 
2014; Yu et al., 2012)
aOne application was coded as not applicable (NA) for this ethical consideration as personal information was not collected 
(Meredith et al., 2014). bOne application was coded as NA for this ethical consideration as it was not invasive to the users 
privacy (V. Patel et al., 2013). cSix applications were coded as NA for this ethical consideration as the apps were used in 
controlled experimental conditions (Freedman et al., 2006; Gamito et al., 2014; Matsumura et al., 2009; Meredith et al., 
2014; Reitzel et al., 2014; Watkins et al., 2014). dSix applications were coded as NA for this ethical consideration as they 
were either used in controlled experimental conditions or were not invasive to the users privacy (Epstein et al., 2009; 
Freedman et al., 2006; Gamito et al., 2014; Matsumura et al., 2009; Meredith et al., 2014; V. Patel et al., 2013). e17 
applications were coded as NA for this ethical consideration as messaging was not included in the features (Ahsan et al., 
2013; BinDhim et al., 2014; Bricker et al., 2014; Epstein et al., 2009; Freedman et al., 2006; Gamito et al., 2014; D. H. 
Gustafson et al., 2014; Hasin et al., 2014; Hertzberg et al., 2013; Matsumura et al., 2009; Meredith et al., 2014; V. Patel et 
al., 2013; Ploderer et al., 2014; Reitzel et al., 2014; Stoner & Hendershot, 2012; Struik & Baskerville, 2014; Watkins et al., 
2014). fFive applications were coded as NA for this ethical consideration as they were part of exploratory/feasibility studies 
(Ahsan et al., 2013; Matsumura et al., 2009; Meredith et al., 2014; V. Patel et al., 2013; Struik & Baskerville, 2014). gOne 
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application was coded as NA for this ethical consideration as the users of the app were not being studied for their personal 
substance abuse (V. Patel et al., 2013).
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